Clinical characteristics, metabolic features, and phenotype of Chinese women with polycystic ovary syndrome: a large-scale case–control study

被引:29
作者
Hong Yuan Zhang
Cheng Xiu Guo
Fu Fan Zhu
Peng Peng Qu
Wan Jun Lin
Jing Xiong
机构
[1] Tianjin Central Gynecology and Obstetrics Hospital,Department of Gynecology
[2] Second Xiangya Hospital of Central South University,Department of Obstetrics and Gynecology
来源
Archives of Gynecology and Obstetrics | 2013年 / 287卷
关键词
Chinese women; Diagnostic criteria; Obesity; Phenotype; Polycystic ovary syndrome;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:525 / 531
页数:6
相关论文
共 112 条
[1]
Broekmans FJ(2006)PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO-II anovulation and association with metabolic factors BJOG 113 1210-1217
[2]
Knauff EA(2011)Diabetes and impaired glucose tolerance in patients with polycystic ovary syndrome—a long term follow-up Hum Reprod 26 1462-1468
[3]
Valkenburg O(2011)Insulin resistance and the long-term consequences of polycystic ovary syndrome J Obstet Gynaecol 31 105-110
[4]
Hudecova M(2000)Polycystic ovary syndrome nomenclature: chaos? Fertil Steril 73 1261-1262
[5]
Holte J(2009)Characteristics of different phenotypes of polycystic ovary syndrome based on the rotterdam criteria in a large-scale Chinese population BJOG 116 1633-1639
[6]
Olovsson M(2004)Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome Fertil Steril 81 19-25
[7]
Larsson A(2011)Difficulties and pitfalls in the diagnosis of polycystic ovary syndrome Arq Bras Endocrinol Metabol 55 6-15
[8]
Berne C(2005)Diagnostic criteria for polycystic ovarian syndrome: a reappraisal Fertil Steril 83 1343-1346
[9]
Poromaa IS(2006)Abnormal glucose tolerance in Chinese women with polycystic ovary syndrome Hum Reprod 21 2027-2032
[10]
Bhathena RK(1999)Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women J Clin Endocrinol Metab 84 165-169